Just diagnosed with ITM2B amyloidosis?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees ITM2B amyloidosis, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive ITM2B amyloidosis hub →Overview
ITM2B amyloidosis is a rare condition. Also known as Familial cerebral amyloid angiopathy, ITM2B-related amyloidosis, ITM2B-related cerebral amyloid angiopathy. Tomeko brings together the specialists, research, clinical trials, treatments and community for ITM2B amyloidosis so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:439254 · OMIM 117300, 176500 · ICD-10 E85.4+, I68.0* · GARD 0017741
Find care for ITM2B amyloidosis
Authoritative references for ITM2B amyloidosis
Research & market landscape for ITM2B amyloidosis
Following ITM2B amyloidosis for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for ITM2B amyloidosis — the real-world landscape behind the condition, in one place.
- Latest ITM2B amyloidosis research on PubMed ↗
- Recruiting ITM2B amyloidosis trials on ClinicalTrials.gov ↗
- Explore the ITM2B amyloidosis research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for ITM2B amyloidosis and every rare condition. See how Tomeko works with industry →
Common questions
What is ITM2B amyloidosis?
ITM2B amyloidosis is a rare condition. Also known as Familial cerebral amyloid angiopathy, ITM2B-related amyloidosis, ITM2B-related cerebral amyloid angiopathy. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for ITM2B amyloidosis together in one place.
What are the symptoms of ITM2B amyloidosis?
Symptoms of ITM2B amyloidosis vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats ITM2B amyloidosis.
How is ITM2B amyloidosis treated?
Treatment for ITM2B amyloidosis depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see ITM2B amyloidosis, and review current options with them.
What causes ITM2B amyloidosis — is it genetic?
The cause and inheritance of ITM2B amyloidosis are described in the authoritative references linked on this page. A genetics or specialist clinician who treats ITM2B amyloidosis can explain what it means for you and your family.
I was just diagnosed with ITM2B amyloidosis — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees ITM2B amyloidosis, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for ITM2B amyloidosis?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat ITM2B amyloidosis, filtered to your area.
Are there clinical trials for ITM2B amyloidosis?
Tomeko shows live, recruiting studies for ITM2B amyloidosis from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- 2-aminoadipic 2-oxoadipic aciduria
- 3 beta-Hydroxysteroid dehydrogenase deficiency
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
- 3-Hydroxyisobutyric aciduria
- 3-hydroxyisobutyryl-CoA hydrolase deficiency
- 3-methylglutaconic aciduria type 1
- 3-Methylglutaconic aciduria type 2
- 3-Methylglutaconic aciduria type 3